Drug information provided by: Merative, Micromedex®
Teplizumab-mzwv injection is used to delay the onset of Stage 3 type 1 diabetes in patients who have Stage 2 type 1 diabetes and who have tested positive for 2 or more type 1 diabetes-related autoantibodies, have an abnormal blood sugar, and do not have type 2 diabetes.
This medicine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2023
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
A generous benefactor has pledged $1 million and challenged us to raise an additional $250,000. Help us reach our goal!